鉴定九基因组合作为子宫内膜异位症无创诊断的新型特异性模型
研究利用公共数据集和加权基因共表达网络分析鉴定差异表达基因,用十种机器学习算法构建九基因面板EMScore模型,在组织样本中AUC为0.920、血液样本中AUC为0.942,并在七个临床队列中优于其他已知标志物。
要点
- 基于九基因mRNA评分(EMScore)可区分子宫内膜异位症患者与健康个体。
- EMScore诊断子宫内膜异位症的AUC在组织样本为0.920、血液样本为0.942。
- EMScore在七个临床队列中预测表现优于其他已知标志物。
核心结论
- 研究开发了EMScore模型,可利用外周血样本辅助诊断子宫内膜异位症,这九基因可能为治疗子宫内膜异位症的潜在靶分子。
研究设计与样本
- 研究使用公共数据集和加权基因共表达网络分析鉴定差异表达基因,采用十种机器学习算法构建预测子宫内膜异位症的整合模型,并用数据集和临床样本验证模型的准确性和稳健性。
- 临床样本来自中国西安空军军医大学唐都医院妇产科,纳入20至40岁需腹腔镜手术且前3个月内未接受激素治疗的患者,健康个体均至少生育过一次,排除炎症性疾病、恶性疾病、免疫疾病、子宫肌瘤或子宫腺肌症患者。
- 收集石蜡包埋样本(病例组n=5,对照组n=5),并采集58例个体的血液样本(病例组n=28,对照组n=30)。
主要发现
- 构建了九基因面板子宫内膜异位症信使RNA评分(EMScore),用于区分子宫内膜异位症患者与健康个体。
- EMScore诊断子宫内膜异位症的受试者工作特征曲线下面积在组织样本为0.920,在血液样本为0.942。
- EMScore在七个临床队列中预测子宫内膜异位症的表现优于其他已知标志物。
关键数值与推荐
- EMScore诊断子宫内膜异位症的AUC:组织样本0.920,血液样本0.942。
临床怎么用
- 原文结论认为EMScore是一种敏感且特异的无创诊断方法,可利用外周血样本辅助诊断子宫内膜异位症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study biomarkers to develop a novel diagnosis model for endometriosis and validate it using clinical samples. DESIGN: We used publicly available data sets and weighted gene coexpression network analysis to identify differentially expressed genes. Ten machine learning algorithms were used to develop an integrative model for predicting endometriosis. The accuracy and robustness of the model were validated using data sets and clinical samples. SETTING: Department of Obstetrics and Gynecology, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China. PATIENT(S): The study included clinical patients between the ages of 20 and 40 years who required laparoscopic surgery and who had not undergone hormone therapy within the previous 3 months. All the healthy individuals had given birth to a child at least once in their lives. Patients with inflammatory conditions, malignant diseases, immune diseases, myoma, or adenomyosis were excluded. Paraffin blocks of the samples were collected (case, n = 5; control, n = 5). Blood samples of 58 individuals were collected (case, n = 28; control, n = 30). INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): The areas under the receiver operator characteristic curve of our diagnostic model were measured for data sets and clinical samples. Multiplex immunohistochemical staining and real-time quantitative polymerase chain reaction assays were used for the validation of the model from tissue slides and peripheral blood samples. RESULT(S): A nine-gene panel endometriosis messenger RNA score (EMScore), was constructed to distinguish the patients with endometriosis from healthy individuals using algorithms. The EMScore accurately predicted endometriosis, and the areas under the receiver operator characteristic curve of our diagnostic model were 0.920, and 0.942 for tissue and blood samples, respectively. Moreover, the EMScore outperformed other acknowledged signatures for predicting endometriosis across seven clinical cohorts. Overall, the EMScore constitutes a sensitive and specific noninvasive diagnostic method for endometriosis. CONCLUSION(S): We developed the EMScore, a novel model that can aid in the diagnosis of endometriosis using peripheral blood samples. This study will contribute to the development of improved clinical noninvasive and sensitive diagnostic tools for endometriosis. These nine genes might be potential target molecules for treating endometriosis.
引用
- Su D, Guo Y, Yang R, et al. Identifying a panel of nine genes as novel specific model in endometriosis noninvasive diagnosis. Fertil Steril. 2023. PMID: 37995798. doi:10.1016/j.fertnstert.2023.11.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。